ThePeptideGuide.uk LogoNavigation

Educational purposes only. Not medical advice. Consult healthcare professionals before use.

Healing & Recovery
Preclinical

IGF-2

IGF-2

Also known as: IGF-II, Somatomedin A

Overview

Key Facts

Primary Goal: Research and therapeutic applications of IGF-2

Binds IGF-1 receptor to activate PI3K/Akt and MAPK/ERK pathways. Binds insulin receptor isoform A (IR-A), particularly relevant in muscle progenitor cells.

Dosing Information

Half-Life

~15 minutes (heavily regulated by IGFBPs and IGF-2R clearance)

Typical Dose

20–100 mcg

Frequency

Once daily (research dosing, not clinically established)

Cycle Length

4-8 weeks (research context only)

Administration Routes:
subcutaneousintramuscular

Benefits

  • Supports satellite cell self-renewal maintaining the stem cell pool
  • Promotes myogenic differentiation during muscle regeneration
  • May enhance muscle recovery without depleting satellite cell reserves
  • Potential role in connective tissue repair and bone healing
  • Complementary to IGF-1 with distinct regenerative signaling kinetics

Side Effects

Hypoglycemia (binds insulin receptor isoform A)mild
Very limited safety data for exogenous administrationmild
Theoretical concern regarding tumor promotion (IGF-2 is overexpressed in some cancers)mild
Rapid clearance by IGF-2R limits effective dose windowmild
Injection site reactionsmild

Mechanism of Action

1

Binds IGF-1 receptor to activate PI3K/Akt and MAPK/ERK pathways

2

Binds insulin receptor isoform A (IR-A), particularly relevant in muscle progenitor cells

3

Promotes asymmetric satellite cell division, maintaining the stem cell niche while generating committed myoblasts

4

Cleared by IGF-2R (mannose-6-phosphate receptor) which directs it to lysosomes

5

Regulated by imprinting — loss of imprinting (LOI) is associated with pathological overgrowth

Contraindications

Do not use this peptide if any of the following apply:

  • Active malignancy or history of IGF-2-overexpressing tumours
  • Beckwith-Wiedemann syndrome or other imprinting disorders
  • Diabetes or insulin-dependent conditions
  • Pregnancy or breastfeeding

Storage & Reconstitution

Unreconstituted (Powder)

Temperature2–8°C (36–46°F) or -20°C (-4°F) for long-term
DurationUp to 3 months

Reconstituted (Mixed)

Temperature2–8°C (36–46°F)
Duration2-4 weeks

Research Summary

Preclinical

IGF-2 has been studied primarily in developmental biology and cancer research. Seminal work by Merrick et al. demonstrated IGF-2's role in satellite cell self-renewal during muscle regeneration in mice. Unlike IGF-1, which drives differentiation, IGF-2 maintains the regenerative capacity of the satellite cell pool. While preclinical evidence is promising for muscle repair applications, no clinical trials for musculoskeletal indications exist. Its complex regulation through genomic imprinting adds a layer of biological nuance absent in other IGF family peptides.

Frequently Asked Questions

Common questions about IGF-2

UK-Specific Information

Exclusive data points and guidance for UK residents using IGF-2

UK Lab Testing

UK Lab Testing

Recommended labs: Medichecks, Thriva (£89-£149 for peptide safety panel)

Why this matters: UK-specific lab testing guidance not available on US competitor sites

Commonly Stacked With

Share on TikTok

Generate a trackable link to share this peptide information on TikTok